PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,660,157 | -19.7% | 354,323 | +1.9% | 0.00% | 0.0% |
| Q2 2023 | $4,558,740 | +26.9% | 347,730 | +8.3% | 0.00% | 0.0% |
| Q1 2023 | $3,591,185 | +34.6% | 321,215 | +1.5% | 0.00% | 0.0% |
| Q4 2022 | $2,668,710 | -48.3% | 316,573 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $5,162,000 | +15.2% | 309,855 | +1.8% | 0.00% | 0.0% |
| Q2 2022 | $4,481,000 | -30.2% | 304,410 | +17.7% | 0.00% | 0.0% |
| Q1 2022 | $6,419,000 | -25.6% | 258,726 | -3.8% | 0.00% | 0.0% |
| Q4 2021 | $8,629,000 | -10.3% | 269,074 | +0.7% | 0.00% | -50.0% |
| Q3 2021 | $9,617,000 | -5.0% | 267,306 | +16.5% | 0.00% | 0.0% |
| Q2 2021 | $10,128,000 | +79.1% | 229,529 | +85.7% | 0.00% | +100.0% |
| Q1 2021 | $5,654,000 | -37.8% | 123,612 | -6.1% | 0.00% | -50.0% |
| Q4 2020 | $9,085,000 | – | 131,621 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |